Foldax Wins IDE for Surgical Aortic Heart Valve Trial

Foldax has received a nod from FDA to begin an early feasibility study of a surgical aortic heart valve. The Salt Lake City, UT-based company said its Tria surgical aortic heart valve is one of the first biopolymer heart valve platforms. The complete Tria heart valve platform will include valves developed for use in aortic, mitral, and tricuspid valve disease. "We look forward to introducing the Tria heart valve to patients in the U.S.", Amit Patel, MD of the University of Utah, who wil...

from A via a.sfakia on Inoreader http://bit.ly/2GAcThR